Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05800587 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. 3 versions Re-verified since Mar 25, 2024, no change to tracked fieldsv2-v4
  2. Study First Submitted
This is an open-label, non-randomized, single-center, phase II study to evaluate the efficacy, toxicity and, tolerability of pre-specified dose attenuated chemotherapy regimens in lung cancer patients with comorbidities.
Trial Details
NCT Number NCT05800587
Lead Sponsor Fox Chase Cancer Center
Conditions
(from sponsor)		 Lung Cancer, Small-cell Lung Cancer, Non Small Cell Lung Cancer
Related terms Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma
Enrollment 280 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov